Cotinga Pharmaceuticals Inc (COTQF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Jun 24, 16:00
Cotinga Pharmaceuticals EPS Diluted (Quarterly): -0.0152 for Jan. 31, 2020
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2020 | -0.0152 |
| October 31, 2019 | -0.0151 |
| July 31, 2019 | -0.0151 |
| April 30, 2019 | -0.03 |
| January 31, 2019 | -0.0075 |
| October 31, 2018 | -0.0153 |
| July 31, 2018 | -0.0307 |
| April 30, 2018 | -0.0785 |
| January 31, 2018 | -0.0632 |
| October 31, 2017 | -0.0879 |
| July 31, 2017 | -0.0151 |
| April 30, 2017 | -0.0977 |
| January 31, 2017 | -0.06 |
| October 31, 2016 | -0.0382 |
| July 31, 2016 | -0.1235 |
| April 30, 2016 | -0.1429 |
| January 31, 2016 | -0.0729 |
| October 31, 2015 | -0.076 |
| July 31, 2015 | -0.0802 |
| April 30, 2015 | -0.08 |
| January 31, 2015 | -0.0859 |
| October 31, 2014 | -0.0905 |
| July 31, 2014 | -0.0925 |
| April 30, 2014 | -0.0904 |
| January 31, 2014 | -0.0936 |
| Date | Value |
|---|---|
| October 31, 2013 | -0.0964 |
| July 31, 2013 | -0.097 |
| April 30, 2013 | 0.00 |
| January 31, 2013 | -0.1007 |
| October 31, 2012 | -0.1014 |
| July 31, 2012 | -0.0982 |
| April 30, 2012 | -0.1005 |
| January 31, 2012 | -0.0979 |
| October 31, 2011 | -0.0998 |
| July 31, 2011 | -0.1034 |
| April 30, 2011 | -0.1025 |
| January 31, 2011 | -0.0995 |
| October 31, 2010 | -0.097 |
| July 31, 2010 | -0.0959 |
| April 30, 2010 | -0.1946 |
| January 31, 2010 | -0.1899 |
| October 31, 2009 | -0.1862 |
| July 31, 2009 | -0.1766 |
| April 30, 2009 | -0.1609 |
| January 31, 2009 | -0.163 |
| October 31, 2008 | -0.1827 |
| July 31, 2008 | -0.198 |
| April 30, 2008 | -0.1989 |
| January 31, 2008 | -0.1006 |
| October 31, 2007 | -0.0983 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.0152
Minimum
Jan 2020
-0.0151
Maximum
Jul 2019
-0.0151
Average
-0.0151
Median
Oct 2019
EPS Diluted (Quarterly) Benchmarks
| Bionoid Pharma Inc | -- |
| Acasti Pharma Inc | -0.3368 |
| Aurinia Pharmaceuticals Inc | -0.18 |
| Edesa Biotech Inc | -0.58 |
| Lexaria Bioscience Corp | -0.06 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.4055M |
| Total Expenses (Quarterly) | 0.3578M |